Eric J. Friedman - 24 Jun 2026 Form 4/A - Amendment Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Reporting relationship: Director
Issuer ticker: INBP
Reported as of: 24 Jun 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 25 Jun 2026, 12:14:30 UTC
Original report date: 24 Jun 2026
Prior SEC filing: 20 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Eric Friedman

Key filing fact

Eric J. Friedman filed Form 4/A - Amendment for INTEGRATED BIOPHARMA INC (INBP) on 25 Jun 2026.

Key facts

This page summarizes Eric J. Friedman's Form 4/A - Amendment filing for INTEGRATED BIOPHARMA INC (INBP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 25 Jun 2026, 12:14.

Change

Previous filing in this sequence was filed on 20 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001216280 Primary reporting owner

FRIEDMAN ERIC J

Relationship: Director
Address: C/O INTEGRATED BIOPHARMA, INC., 225 LONG AVENUE, BLDG 15, HILLSIDE
Signature: /s/ Eric Friedman
Signature date: 25 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INBP transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +50,000
Change %
Price: $0.000000^*
Shares after: 50,000
Date: 24 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $0.1900
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027.

SEC remarks

This Amendment corrects Box 9 - Number of Derivative Securities Beneficially Owned Following Reported Transaction from 50 to 50,000.